Glasdegib Plus Intensive vs Non-Intensive Chemotherapy for Untreated AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial
Leukemia 2023 Aug 21;[EPub Ahead of Print], MA Sekeres, P Montesinos, J Novak, J Wang, D Jeyakumar, B Tomlinson, J Mayer, E Jou, T Robak, DC Taussig, H Dombret, A Merchant, N Shaik, T O'Brien, W Roh, X Liu, W Ma, CG DiRienzo, G Chan, JE CortesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.